Brief: RXO Q4 Adjusted EPS USD 0.06 Vs. IBES Estimate USD 0.06
Feb 05 (Reuters) - RXO Q4 revenue USD 2,000 million vs. IBES estimate USD 1,664 million. * Q4 adjusted EBITDA USD 42 million vs. IBES estimate USD 41.5 million * Q4 adjusted net income USD 10 million vs. IBES estimate USD 9.69 million * Q4 EPS USD -0.12 * Q4 adjusted EBITDA margin 2.5%